Study guide

16.2 Pregnancy, Placenta & Developmental Toxicology

NBME Comprehensive Basic Science Examination CBSE

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Navigation

1.1 Current Exam Facts & Administration 1.2 Content Blueprint & Physician Tasks 1.3 Scoring, Score Reports & Step 1 Readiness

2 Human Development

2.1 Embryology & Congenital Development Patterns 2.2 Normal Age-Related Findings & Well-Patient Care

3 Blood & Hematologic Disease

3.1 Hematopoiesis, RBC Disorders & Anemias 3.2 Hemostasis, Thrombosis & Coagulopathies 3.3 WBC Disorders, Leukemia & Lymphoma Mechanisms

4 Immune System

4.1 Innate & Adaptive Immunity Mechanisms 4.2 Hypersensitivity, Autoimmunity & Immunodeficiency 4.3 Transplant Immunology & Immune Pharmacology

5 Nervous System Anatomy & Disease

5.1 Neuroanatomy Localization & Pathways 5.2 Stroke, Infection, Demyelination & Trauma 5.3 Seizures, Movement Disorders & Neurodegeneration 5.4 Special Senses: Eye & Ear Mechanisms

6 Behavioral Health

6.1 Psychiatric Disorders & Diagnostic Patterns 6.2 Psychopharmacology Mechanisms 6.3 Neurotransmitters, Learning & Behavioral Science

7 Musculoskeletal System

7.1 Bone Physiology, Fracture Healing & Bone Pathology 7.2 Joint Disease, Rheumatology & Connective Tissue 7.3 Muscle, NMJ & Peripheral Nerve Disorders

8 Skin & Soft Tissue

8.1 Dermatopathology High-Yield Lesions 8.2 Inflammation, Wound Healing & Soft-Tissue Infection

9 Cardiovascular Pathophysiology

9.1 Cardiac Cycle, Hemodynamics & Murmurs 9.2 Ischemic Heart Disease & Cardiomyopathy 9.3 Congenital & Valvular Heart Disease 9.4 Vascular Pathology & Hypertension

10 Cardiovascular Pharmacology

10.1 Antihypertensives, Heart Failure & Antiarrhythmics 10.2 Antiplatelets, Anticoagulants & Lipid Drugs

11 Respiratory System

11.1 Pulmonary Mechanics & Gas Exchange 11.2 Obstructive, Restrictive & Vascular Lung Disease 11.3 Pulmonary Infections, Neoplasms & Respiratory Pharmacology

12 Renal Physiology & Electrolytes

12.1 Nephron Transport & Renal Physiology 12.2 Electrolyte Disorders 12.3 Acid-Base Physiology & Compensation

13 Renal Pathology

13.1 Glomerular Disease Mechanisms 13.2 Tubulointerstitial, Vascular & Stone Disease

14 Gastrointestinal System

14.1 GI Physiology, Motility & Digestion 14.2 Esophagus, Stomach & Intestinal Pathology 14.3 Liver, Biliary Tree & Pancreas 14.4 GI Microbiology, Nutrition & Malabsorption

15 Endocrine System

15.1 Hormone Signaling & Hypothalamic-Pituitary Axes 15.2 Thyroid & Parathyroid Disease 15.3 Adrenal Disorders & Steroid Pharmacology 15.4 Diabetes, Glucose Homeostasis & Metabolic Syndrome

16 Reproductive System

16.1 Male & Female Reproductive Physiology 16.2 Pregnancy, Placenta & Developmental Toxicology 16.3 Reproductive Pathology & Hormone-Related Neoplasia

17 Multisystem Processes & Disorders

17.1 Cell Injury, Inflammation & Repair 17.2 Neoplasia Principles & Tumor Biology 17.3 Infection, Sepsis & Multisystem Microbial Disease 17.4 Genetics, Inborn Errors & Environmental Toxicology

18 Biostatistics & Epidemiology

18.1 Study Design, Bias & Causation 18.2 Diagnostic Test Metrics & Screening 18.3 Epidemiology Measures & Population Health

19 Social Sciences & Communication

19.1 Ethics Principles & Decision-Making Capacity 19.2 Communication Skills & Difficult Conversations 19.3 Professionalism, Systems & Practice-Based Learning

20 Integrated Disciplines Capstone

20.1 High-Yield Microbiology Anchors Across Systems 20.2 High-Yield Biochemistry & Molecular Mechanisms 20.3 Integrated Pharmacology Strategy & Exam-Day Execution

16.2 Pregnancy, Placenta & Developmental Toxicology

Key Takeaways Explain This Topic AI

Syncytiotrophoblast invades and produces hCG and later pregnancy hormones; cytotrophoblast is the mitotically active inner layer that feeds the syncytium. hCG maintains the corpus luteum early; hPL contributes to maternal insulin resistance.

Maternal adaptations: ↑ blood volume and CO, dilutional anemia, hypercoagulability, ↑ GFR (lower creatinine/urea), ↑ minute ventilation with chronic respiratory alkalosis, and relative immunosuppression at the maternal–fetal interface.

Fetal circulation: umbilical vein (oxygenated) → ductus venosus → IVC → foramen ovale / RV→ductus arteriosus pathways; umbilical arteries return deoxygenated blood to placenta. At birth, PVR falls, FO and DA close functionally.

Teratogen risk is highest during organogenesis (≈weeks 3–8); later exposures more often cause growth restriction or functional deficits. Classic agents: isotretinoin, valproate, warfarin, ACE inhibitors, alcohol, DES, thalidomide, tetracyclines, aminoglycosides.

TORCH infections produce overlapping congenital syndromes (IUGR, microcephaly or hydrocephalus, chorioretinitis, calcifications, hepatosplenomegaly, rash); organism-specific patterns (e.g., periventricular vs cortical calcifications) refine the diagnosis.

Last updated: August 2026

16.2 Pregnancy, Placenta & Developmental Toxicology

Quick Answer: Syncytiotrophoblast makes hCG/hPL and is the invasive endocrine surface; cytotrophoblast replenishes it. Pregnancy raises volume, CO, GFR, ventilation, and clotting tendency. Fetal shunts (DV, FO, DA) bypass lungs/liver; they close after birth when PVR falls. Organogenesis (weeks 3–8) is the critical teratogen window. Memorize signature teratogens and TORCH patterns.

This section integrates embryologic timing with maternal physiology and toxicology—high-frequency CBSE/Step 1 territory because one vignette can ask for the placental product, the expected maternal lab shift, or the drug that caused a specific birth defect cluster.

Placental Structure and Endocrine Function

After implantation, trophoblast differentiates into:

Cytotrophoblast: mononuclear, mitotically active inner layer; progenitor population.

Syncytiotrophoblast: multinucleated outer layer formed by fusion of cytotrophoblasts; invades endometrium; contacts maternal blood in lacunae; primary site of hormone synthesis and nutrient/gas exchange interface with chorionic villi.

Chorionic villi branch and mature: tertiary villi contain fetal capillaries. Maternal blood in intervillous spaces bathes syncytiotrophoblast (hemochorial placenta). The placental barrier filters some pathogens and drugs imperfectly—many small lipophilic molecules cross freely.

Key placental hormones

Hormone Source timing Main roles

hCG Syncytiotrophoblast; peaks ~8–10 weeks, then declines Maintains corpus luteum progesterone early; structural homology with LH (same α subunit as TSH/FSH/LH—can stimulate thyroid at very high levels); urine/serum pregnancy tests

hPL (human placental lactogen / chorionic somatomammotropin) Rises through pregnancy Maternal insulin resistance , lipolysis—spares glucose for fetus; contributes to gestational diabetes risk

Progesterone Corpus luteum early → placenta later Maintains endometrium/myometrial quiescence

Estrogens (estriol useful clinically) Fetal adrenal DHEA-S → placental aromatization Uterine blood flow, breast development; falling estriol can flag fetal adrenal/placental dysfunction

Clinical links: Multiple gestation or molar pregnancy → very high hCG → possible hyperemesis, theca-lutein cysts, or transient hyperthyroidism. Low hCG or abnormal rise raises concern for ectopic or failing pregnancy (with clinical correlation).

Maternal Physiologic Adaptations

Pregnancy is a high-flow, low-resistance, prothrombotic state with renal and respiratory resets.

System Adaptation Exam implication

Blood volume / CO Plasma volume ↑ ~40–50%; RBC mass ↑ less → dilutional anemia ; CO ↑ (↑SV and HR) "Anemia of pregnancy" can be physiologic; true iron deficiency still common

Blood pressure Early/mid ↓ SVR (progesterone, NO, volume redistribution); CO up BP often lowest mid-pregnancy; hypertension is never "explained away" by pregnancy alone

Coagulation ↑ factors (I, VII, VIII, X), ↓ protein S, venous stasis Hypercoagulable —DVT/PE risk; Virchow triad active

Renal ↑ GFR ~50%; mild glycosuria can occur; dilated collecting systems Lower creatinine/BUN expected; "normal" nonpregnant creatinine may mean reduced GFR in pregnancy

Respiratory ↑ tidal volume / minute ventilation (progesterone); ↓ PaCO₂ Chronic compensated respiratory alkalosis ; dyspnea common

GI ↓ motility, ↓ LES tone Constipation, GERD; delayed drug absorption possible

Endocrine / metabolic Insulin resistance (hPL, others); ↑ TBG → ↑ total T4 with normal free hormones if euthyroid Gestational diabetes screening; interpret thyroid labs carefully

Heme ↑ WBC mild; gestational thrombocytopenia mild possible Extreme values still pathologic

Immunologic note: Local tolerance mechanisms at the placenta (HLA-G, regulatory T cells, altered Th balance) allow the semi-allogeneic fetus to persist; systemic immunity is not globally "off," but certain infections (e.g., listeria) are more dangerous.

Amniotic Fluid

Amniotic fluid is produced from fetal urine (major source later), lung liquid, and membrane secretions; removed by fetal swallowing and intramembranous pathways.

Polyhydramnios: excess fluid—think impaired swallowing (anencephaly, GI obstruction such as duodenal atresia), maternal diabetes, twin–twin transfusion (recipient).

Oligohydramnios: deficit—renal agenesis/bilateral obstruction (Potter sequence), placental insufficiency, preterm rupture of membranes. Potter facies, pulmonary hypoplasia, limb deformities follow severe oligohydramnios.

Fetal Circulation Review

Oxygenated blood returns from placenta via umbilical vein → majority through ductus venosus to IVC (bypassing hepatic sinusoids) → right atrium. Preferential streaming directs blood through foramen ovale to left atrium → left ventricle → brain/heart. Deoxygenated superior vena cava blood prefers RV → pulmonary artery → ductus arteriosus → descending aorta (lungs are high-resistance fluid-filled circuits receiving little flow). Two umbilical arteries return blood to the placenta.

At birth: lung expansion ↓ pulmonary vascular resistance → ↑ pulmonary venous return → left atrial pressure rises → foramen ovale functional closure. Rising PaO₂ and falling prostaglandins close ductus arteriosus . Umbilical vessels constrict; ductus venosus closes. Persistent pulmonary hypertension or PDA physiology appears when these transitions fail.

Teratogens and Critical Periods

  • Developmental window Typical vulnerability
  • Weeks 1–2 (pre-implantation) "All or none"—lethality or recovery; classic malformations less likely
  • Weeks 3–8 ( organogenesis ) Major structural teratogenesis peak

Week 9–term (fetal period) Growth restriction, organ hypoplasia, functional CNS effects, stillbirth; some structures (CNS, genitalia, teeth) remain sensitive

Classic teratogens (mechanism + pattern)

Agent Mechanism / notes Signature pattern

Isotretinoin (vitamin A analog) Disrupts HOX/neural crest patterning Craniofacial dysmorphism, thymic and cardiac neural-crest defects, CNS anomalies

Valproate Impaired folate-related neural tube closure / gene expression Neural tube defects (e.g., meningomyelocele), craniofacial features, cognitive risk

Warfarin Vitamin K–dependent process disruption in fetus Nasal hypoplasia, stippled epiphyses, limb hypoplasia; later CNS hemorrhage risk

ACE inhibitors / ARBs Fetal renal hypoperfusion (RAAS critical for fetal kidney) Renal dysgenesis , oligohydramnios, skull hypoplasia, Potter-like sequence

Alcohol Multifactorial CNS toxicity Fetal alcohol spectrum: smooth philtrum, thin vermillion, short palpebral fissures, microcephaly, intellectual disability

DES (diethylstilbestrol) Estrogenic endocrine disruption Female offspring: vaginal clear cell adenocarcinoma , T-shaped uterus, cervical anomalies; male reproductive tract anomalies

Thalidomide Cereblon / angiogenic disruption (historical sedative) Phocomelia / limb reduction, ear and cardiac defects

Tetracyclines Chelate calcium in teeth/bone Tooth discoloration , enamel hypoplasia; impaired bone growth concerns

Aminoglycosides Ototoxicity Congenital deafness (CN VIII)

Methotrexate / folate antagonists Impaired DNA synthesis Neural tube and other malformations; growth restriction

  • Carbamazepine Neural tube risk (less than valproate but tested) Neural tube defects, craniofacial features
  • Lithium Cardiac developmental interference Ebstein anomaly association

Tobacco / cocaine Vasoconstriction, hypoxia Growth restriction, placental abruption risk (cocaine), preterm birth

Prescribing pearl for exams: Switch warfarin to heparin/LMWH in pregnancy when anticoagulation is required (heparins do not cross placenta well). Avoid ACEI/ARB; use pregnancy-safe antihypertensives (labetalol, nifedipine, hydralazine—context dependent). High-dose vitamin A / isotretinoin: absolute avoidance with contraception programs.

TORCH and Congenital Infection Patterns

TORCH traditionally: T oxoplasma, O thers (syphilis, VZV, parvovirus B19, Zika, etc.), R ubella, C MV, H SV. Shared themes: IUGR, microcephaly or hydrocephalus, intracranial calcifications, chorioretinitis, hepatosplenomegaly, jaundice, petechiae/"blueberry muffin" dermal erythropoiesis, sensorineural hearing loss, thrombocytopenia.

Organism High-yield discriminators

Toxoplasma Undercooked meat / cat feces; chorioretinitis , hydrocephalus, intracranial calcifications (diffuse)

CMV Most common congenital viral infection; periventricular calcifications , hearing loss, microcephaly, thrombocytopenia

Rubella Cataracts, PDA / cardiac defects (e.g., pulmonary artery stenosis), sensorineural deafness, blueberry muffin; preventable by maternal immunity

HSV Usually peripartum acquisition; SEM (skin-eye-mouth), CNS, or disseminated disease; intrauterine infection less common but severe

Syphilis Snuffles, maculopapular rash including palms/soles, hepatomegaly, osteochondritis, later Hutchinson teeth/saddle nose

  • Parvovirus B19 Fetal anemia , hydrops (infects erythroid precursors)
  • Zika Severe microcephaly, brain anomalies, ocular defects

Timing: First-trimester infection often yields more severe structural disease for many TORCH agents; peripartum HSV is about exposure during delivery with active shedding.

Integration Strategy

When a stem gives a birth defect cluster, first date the exposure (organogenesis vs fetal period), then match drug or infection signature , then check whether maternal physiology would alter the "normal" lab cutoffs. When a stem gives high hCG and hyperthyroid symptoms, remember subunit homology. When oligohydramnios appears after ACEI exposure, connect fetal renal RAAS failure to Potter pathophysiology. Fetal circulation questions almost always hinge on which shunt is patent or which vessel carries the highest oxygen content ( umbilical vein ).